threitolceramide 6 lipsomal
portage
['imm60']
$prtg finally seeing some press on remarkable early clinical observations @ #asco22 activating an immune response with their inkt platform imm60 , recruiting dendretic t cells ,nk cells, and direct tumor killing ! amazing and pioneering! up 20% 
Micro Cap Biotech Investor